EXCITE: A PHASE II TRIAL OF PREOPERATIVE CETUXIMAB, IRINOTECAN AND CAPECITABINE PLUS RADIOTHERAPY (RT) IN MRI-DEFINED LOCALLY ADVANCED RECTAL CANCER (LARC)

被引：0
|
作者：
Gollins, S. [1 ]
Myint, A. S. [2 ]
Saunders, M. P. [3 ]
Susnerwala, S. [4 ]
Sebag-Montefiori, D. [5 ]
Beare, S. [6 ]
Williams, E. [6 ]
West, N. [5 ]
Jitlal, M. [6 ]
机构：
[1] N Wales Canc Treatment Ctr, Rhyl, Wales
[2] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[3] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[4] Royal Preston Hosp, Preston, Lancs, England
[5] Univ Leeds, Leeds, W Yorkshire, England
[6] UCL, CR UK & UCL Canc Trials Ctr, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [41] Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
    Garcia, Margarita
    Martinez-Villacampa, Mercedes
    Santos, Cristina
    Navarro, Valentin
    Teule, Alex
    Losa, Ferran
    Pisa, Aleydis
    Cambray, Maria
    Soler, Gemma
    Lema, Laura
    Kreisler, Esther
    Figueras, Agnes
    Juan, Xavier San
    Vinals, Francesc
    Biondo, Sebastiano
    Salazar, Ramon
    BMC CANCER, 2015, 15
  • [42] A phase II study of capecitabine and concomitant boost radiotherapy (XRT) in patients (pts) with locally advanced rectal cancer (LARC).
    Lin, EH
    Skibber, J
    Delcos, M
    Eng, C
    Christopher, C
    Brown, T
    Vadhan, S
    Hoff, P
    Rodriguez-Bigas, M
    Janjan, NA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 269S - 269S
  • [43] A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
    F Willeke
    K Horisberger
    U Kraus-Tiefenbacher
    F Wenz
    A Leitner
    A Hochhaus
    R Grobholz
    A Willer
    G Kähler
    S Post
    R-D Hofheinz
    British Journal of Cancer, 2007, 96 : 912 - 917
  • [44] A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
    Willeke, F.
    Horisberger, K.
    Kraus-Tiefenbacher, U.
    Wenz, F.
    Leitner, A.
    Hochhaus, A.
    Grobholz, R.
    Willer, A.
    Kaehler, G.
    Post, S.
    Hofheinz, R-D
    BRITISH JOURNAL OF CANCER, 2007, 96 (06) : 912 - 917
  • [45] A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer
    Jo, Hyunji
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Yu, Jeong Il
    Park, Hee Chul
    Choi, Doo Ho
    Park, Yoonah
    Cho, Yong Beom
    Huh, Jung Wook
    Yun, Seong Hyeon
    Kim, Hee Cheol
    Lee, Woo Yong
    Kang, Won Ki
    CANCER RESEARCH AND TREATMENT, 2023, 55 (01): : 189 - 195
  • [46] Preoperative capecitabine, oxaliplatin and high-dose pelvic conformal radiotherapy in locally advanced rectal cancer (LARC).
    Tucci, E
    Algeri, R
    Giulianotti, PC
    Pecci, AP
    Schiaroli, G
    Sbrana, F
    Perillo, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 281S - 281S
  • [47] Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer - A two stage phase II clinical trial
    Resch, Gudrun
    De Vries, Alexander
    Oefner, Dietrnar
    Eisterer, Wolfgang
    Rabl, Hans
    Jagoditsch, Michael
    Gnant, Michael
    Thaler, Josef
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 (01) : 10 - 13
  • [48] Preoperative Radiotherapy with Capecitabine, Oxaliplatin and Cetuximab in the Treatment of locally advanced Rectal Carcinoma: Long Term Results of a Phase II Study
    Weiss, C.
    Liersch, T.
    Arnold, D.
    Dellas, K.
    Hinke, A.
    Hipp, M.
    Balermpas, P.
    Roedel, F.
    Sauer, R.
    Roedel, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 122 - 122
  • [49] Preoperative chemoradiation (CRT) with concurrent capecitabine and irinotecan in MRI-defined locally advanced rectal cancer: Relationship of histologic downstaging to long-term survival end points.
    Gollins, S. W.
    Myint, S.
    Susnerwala, S.
    Wise, M.
    Haylock, B. J.
    Saunders, M. P.
    Neupane, R.
    Topham, C.
    Samuel, L. M.
    Levine, E. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
    Lee, Sung Uk
    Kim, Dae Yong
    Kim, Sun Young
    Baek, Ji Yeon
    Chang, Hee Jin
    Kim, Min Ju
    Kim, Tae Hyun
    Park, Ji Won
    Oh, Jae Hwan
    RADIATION ONCOLOGY, 2013, 8
12345